Subjective response to neuroleptics: The effect of a questionnaire about neuroleptic side effects

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 6, 2006, Pages 1139-1142

  Taira, M ^a   Hashimoto, T ^a   Takamatsu, T ^a   Maeda, K ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Neuroleptics; Questionnaire; Schizophrenia; Side effects; Subjective response

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; DISTRESS SYNDROME; DRUG ATTITUDE INVENTORY; DRUG RESPONSE; EVALUATION; FEMALE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MENTAL PATIENT; OUTPATIENT; PATIENT ATTITUDE; PATIENT PARTICIPATION; QUESTIONNAIRE; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33745477116     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.05.002     Document Type: Article

References (15)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Forth Edition (1994) Washington, DC.
2. Awad A.G. Subjective response to neuroleptics in schizophrenia. Schizophr Bull 19 3 (1993) 609-618
3. Awad A.G., and Hogan T.P. Subjective response to neuroleptics and the quality of life: implications for treatment outcome. Acta Psychiatr Scand 89 Suppl. 380 (1994) 27-32
4. Corrigan P.W., Liberman R.P., and Engle J.D. From noncompliance to collaboration in the treatment of schizophrenia. Hosp Commun Psychiatry 41 (1990) 1203-1211
5. Dott S.G., Weiden P.J., Hopwood P., Awad A.G., Hellewell J.S., Knesevich J., Kopala L., Miller A., and Salzman C. The Approaches to Schizophrenia Communication (ASC) checklists. CNS Spectr 6 4 (2001) 333-338
6. Eisen S.V., Dickey B., and Sederer L.I. A self-report symptom and problem rating scale to increase in patients' involvement in treatment. Psychiatr Serv 51 3 (2000) 349-353
7. Hogan T.P., Awad A.G., and Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13 (1983) 177-183
8. Inada T., Beasley Jr. C.M., Tanaka Y., and Walker D.J. Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapin or haloperidol. Int Clin Psychophamacol 18 1 (2003) 39-48
9. Naber D. A self-rating to measure subjective effects of neuroleptic drugs relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 10 3 (1995) 133-138
10. Overall J.E., and Gorham D.R. The Brief Psychiatric Rating Scale. Psychol Rep 10 (1962) 799-812
11. Van Os J., Altamura A.C., Bobes J., Owens B.C., Gerlach J., Hellewell J.S., Kasper S., Naber D., Tarrier N., and Robert P. 2-COM: an instrument to facilitate patient-professional communication in routine clinical practice. Acta Psychiatr Scand 106 6 (2002) 446-452
12. Van Os J., Altamura A.C., Bobes J., Gerlach J., Hellewell J.S., Kasper S., and Naber D. Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of a multinational, randomised controlled trial. Br J Psychiatry 184 (2004) 79-83
13. Van Putten T. Why do schizophrenia patients refuse to take their drugs?. Arch Gen Psychiatry 31 (1974) 67-72
14. Weiden P., Mann J.J., Dixon L., Haas G., DeChillo N., and Frances A.J. Is neuroleptic dysphoria a healthy response?. Compr Psychiatry 30 (1989) 546-552
15. Weiden P.J., and Miller A.L. Which side effects really matter? Screening for common and distressing side effects of neuroleptic medications. J Psychiatr Pract 7 (2001) 41-47